R.P. Carrion
Hospital Universitario Quirónsalud Madrid(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Estrogen and related hormone effects, Cancer Treatment and Pharmacology, Lung Cancer Research Studies
Most-Cited Works
- Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.(1994)
- → A Randomised Comparison of Oestrogen Suppression with Anastrozole and Formestane in Postmenopausal Patients with Advanced Breast Cancer(1997)21 cited
- → Phase IV study of first-line bevacizumab plus irinotecan and infusional 5-FU/LV in patients with metastatic colorectal cancer: AVIRI(2007)10 cited
- → Efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-FU as first-line treatment for patients with metastatic colorectal cancer(2006)9 cited
- → Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study(2021)6 cited
- → PP-8-5 A randomised study assessing oestrogen suppression with arimidex™ (Anastrozole) and formestane in postmenopausal advanced breast cancer (ABC) patients(1996)5 cited
- → Erlotinib as a Single Agent in Select Subsets of Patients with Advanced Non–Small-Cell Lung Cancer(2007)4 cited
- → Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (GV/IV) in advanced non-small cell lung cancer. Interim analysis of a Spanish Lung Cancer Group (SLCG) phase III trial(2000)3 cited
- Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study.(2015)
- → Contents, Supplement 2, 1997(1997)